Crinetics Pharmaceuticals Inc (CRNX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2024 | 06-2024 | 03-2024 | 12-2023 | 09-2023 | |
| Sales | 0 | 399 | 640 | 0 | 346 |
| Gross Profit | N/A | 399 | 640 | 0 | 346 |
| Operating Expenses | 87,797 | 83,182 | 74,169 | 62,658 | 59,323 |
| Operating Income | -87,797 | -82,783 | -73,529 | -62,658 | -58,977 |
| Other Income | 10,969 | 8,728 | 6,599 | 2,561 | 1,519 |
| Pre-tax Income | -76,828 | -74,055 | -66,930 | -60,097 | -57,458 |
| Net Income Continuous | -76,828 | -74,055 | -66,930 | -60,097 | -57,458 |
| Net Income | $-76,828 | $-74,055 | $-66,930 | $-60,097 | $-57,458 |
| EPS Basic Total Ops | -0.96 | -0.94 | -0.93 | -0.89 | -1.01 |
| EPS Basic Continuous Ops | -0.96 | -0.94 | -0.93 | -0.89 | -1.01 |
| EPS Diluted Total Ops | -0.96 | -0.94 | -0.93 | -0.89 | -1.01 |
| EPS Diluted Continuous Ops | -0.96 | -0.94 | -0.93 | -0.89 | -1.01 |
| EPS Diluted Before Non-Recurring Items | -0.96 | -0.94 | -0.93 | N/A | N/A |
| EBITDA(a) | $-90,540 | $-85,438 | $-76,902 | $-65,980 | $-59,950 |